OSI Systems Announces Launch of the MCare 300 Low Acuity Patient Monitor
27 November 2006 - 8:00PM
Business Wire
OSI Systems, Inc. (NASDAQ:OSIS), a vertically-integrated provider
of specialized electronic products for critical applications in the
Security and Healthcare industries, announced today that it has
expanded its patient monitoring product portfolio with the launch
of the MCare 300 low acuity patient monitor. The MCare 300 is a
stand alone low acuity patient monitor as compared to the Company�s
successful UltraviewSL patient monitor product line which is fully
networked within the hospital's IT infrastructure. The MCare 300
can be customized to meet the customers� specifications for patient
parameters to be monitored. Standard configuration includes 3 and 5
lead electrocardiogram (�ECG�), respiration, SPO2, temperature and
non-invasive blood pressure monitoring. The monitor utilizes the
same touch screen interface as the UltraviewSL product line and is
equipped with internal default alarms that can be configured for
adult, pediatric and neonatal patients. The product is ideally
suited for day surgery centers and also traditional hospitals where
it could be used as a step down unit bridging the gap between their
high-end networked monitoring systems and stand alone monitoring.
The monitor will be available in nineteen languages and distributed
internationally through the Company�s distributors and direct sales
force. Distribution within the U.S. follows receipt earlier of
510(k) approval from the U.S. Food and Drug Administration (�FDA�)
permitting the MCare 300 to be distributed in the United States
market. Deepak Chopra, OSI Systems� CEO, stated, �The launch of the
new MCare 300 low acuity patient monitor is an important step in
growing our patient monitoring business internationally, especially
in the emerging markets of India and China. The product was
designed and developed to specifically address the opportunity in
the growing day surgery center market while also enabling us to
provide a stand alone patient monitor to our traditional customer
base. While the day surgery center market is a new market for us,
we intend to utilize our strong global brand recognition and
extensive international distribution channels to make the launch a
success.� About OSI Systems, Inc. OSI Systems, Inc. is a Hawthorne,
California based vertically-integrated provider of specialized
electronic products for critical applications in the Security and
Healthcare industries. The company has more than 30 years of
experience in electronics engineering and manufacturing and
maintains offices and production facilities located in more than a
dozen countries. OSI Systems implements a strategy of expansion by
leveraging its electronics and contract manufacturing capabilities
into selective end product markets through organic growth and
acquisitions. For more information on OSI Systems Inc. or any of
its subsidiary companies, visit www.osi-systems.com. About
Spacelabs Healthcare, Inc. Spacelabs Healthcare, Inc.
(www.spacelabshealthcare.com) is an international developer,
manufacturer and distributor of medical equipment and services
including patient monitoring solutions, anesthesia delivery and
ventilation systems, diagnostic cardiology solutions and supplies
and accessories selling to hospitals, clinics and physicians
offices. Additionally, the company provides ECG laboratory services
to pharmaceutical companies undertaking clinical trials, whereby
patient ECG data is recorded, analyzed, tabulated and interpreted.
The company has established brand names in both medical devices and
medical services such as "Spacelabs," "Blease," �Del Mar Reynolds�
and "Dolphin." It employs approximately 1,500 personnel in its
offices located in the United States, UK, Canada, France, Germany,
Finland, India and Singapore. This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Such statements
include information regarding the Company�s expectations, goals or
intentions about the future, including, but not limited to,
statements regarding the launch of the MCare 300, locations where
it will be used by customers, languages in which it will operate,
and the resources that the Company will utilize in the launch of
this product. The actual results may differ materially from those
described in or implied by any forward-looking statement. Other
important factors are set forth in the Securities and Exchange
Commission filings of OSI Systems, Inc. All forward-looking
statements speak only as of the date made, and we undertake no
obligation to update these forward-looking statements. OSI Systems,
Inc. (NASDAQ:OSIS), a vertically-integrated provider of specialized
electronic products for critical applications in the Security and
Healthcare industries, announced today that it has expanded its
patient monitoring product portfolio with the launch of the MCare
300 low acuity patient monitor. The MCare 300 is a stand alone low
acuity patient monitor as compared to the Company's successful
UltraviewSL patient monitor product line which is fully networked
within the hospital's IT infrastructure. The MCare 300 can be
customized to meet the customers' specifications for patient
parameters to be monitored. Standard configuration includes 3 and 5
lead electrocardiogram ("ECG"), respiration, SPO2, temperature and
non-invasive blood pressure monitoring. The monitor utilizes the
same touch screen interface as the UltraviewSL product line and is
equipped with internal default alarms that can be configured for
adult, pediatric and neonatal patients. The product is ideally
suited for day surgery centers and also traditional hospitals where
it could be used as a step down unit bridging the gap between their
high-end networked monitoring systems and stand alone monitoring.
The monitor will be available in nineteen languages and distributed
internationally through the Company's distributors and direct sales
force. Distribution within the U.S. follows receipt earlier of
510(k) approval from the U.S. Food and Drug Administration ("FDA")
permitting the MCare 300 to be distributed in the United States
market. Deepak Chopra, OSI Systems' CEO, stated, "The launch of the
new MCare 300 low acuity patient monitor is an important step in
growing our patient monitoring business internationally, especially
in the emerging markets of India and China. The product was
designed and developed to specifically address the opportunity in
the growing day surgery center market while also enabling us to
provide a stand alone patient monitor to our traditional customer
base. While the day surgery center market is a new market for us,
we intend to utilize our strong global brand recognition and
extensive international distribution channels to make the launch a
success." About OSI Systems, Inc. OSI Systems, Inc. is a Hawthorne,
California based vertically-integrated provider of specialized
electronic products for critical applications in the Security and
Healthcare industries. The company has more than 30 years of
experience in electronics engineering and manufacturing and
maintains offices and production facilities located in more than a
dozen countries. OSI Systems implements a strategy of expansion by
leveraging its electronics and contract manufacturing capabilities
into selective end product markets through organic growth and
acquisitions. For more information on OSI Systems Inc. or any of
its subsidiary companies, visit www.osi-systems.com. About
Spacelabs Healthcare, Inc. Spacelabs Healthcare, Inc.
(www.spacelabshealthcare.com) is an international developer,
manufacturer and distributor of medical equipment and services
including patient monitoring solutions, anesthesia delivery and
ventilation systems, diagnostic cardiology solutions and supplies
and accessories selling to hospitals, clinics and physicians
offices. Additionally, the company provides ECG laboratory services
to pharmaceutical companies undertaking clinical trials, whereby
patient ECG data is recorded, analyzed, tabulated and interpreted.
The company has established brand names in both medical devices and
medical services such as "Spacelabs," "Blease," "Del Mar Reynolds"
and "Dolphin." It employs approximately 1,500 personnel in its
offices located in the United States, UK, Canada, France, Germany,
Finland, India and Singapore. This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Such statements
include information regarding the Company's expectations, goals or
intentions about the future, including, but not limited to,
statements regarding the launch of the MCare 300, locations where
it will be used by customers, languages in which it will operate,
and the resources that the Company will utilize in the launch of
this product. The actual results may differ materially from those
described in or implied by any forward-looking statement. Other
important factors are set forth in the Securities and Exchange
Commission filings of OSI Systems, Inc. All forward-looking
statements speak only as of the date made, and we undertake no
obligation to update these forward-looking statements.
OSI Systems (NASDAQ:OSIS)
Historical Stock Chart
From Jun 2024 to Jul 2024
OSI Systems (NASDAQ:OSIS)
Historical Stock Chart
From Jul 2023 to Jul 2024